Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0IA8W
|
|||
| Drug Name |
BMS-986156
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Phase 2 | [1] | |
| Company |
Bristol-Myers Squibb Princeton, NJ
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The promise and challenges of immune agonist antibody development in cancer. Nat Rev Drug Discov. 2018 Jul;17(7):509-527. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.